MMP2 and neoplasm: For example, PEG-PLA bridged with a synthetic polypeptide PVGLIG sensitive to matrix metalloproteinase 2 (MMP2) overexpressed in tumor extracellular matrix exhibited a seven-fold increase in SN38 release compared to the control formulation [24].